Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Amandine Gouverneur"'
Autor:
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Philippe Devillier
Publikováno v:
The Lancet Regional Health. Europe, Vol 46, Iss , Pp 101120- (2024)
Externí odkaz:
https://doaj.org/article/ce9e63e521824bfa8837e1fa305a6523
Autor:
Pascal Demoly, Mathieu Molimard, Jean-François Bergmann, Bertrand Delaisi, Amandine Gouverneur, Jade Vadel, Cédric Collin, Laurence Girard, Silvia Scurati, Philippe Devillier
Publikováno v:
The Lancet Regional Health. Europe, Vol 41, Iss , Pp 100915- (2024)
Summary: Background: The only disease-modifying treatment currently available for allergic rhinitis (AR) is allergen immunotherapy (AIT). The main objective of the EfficAPSI real-world study (RWS) was to evaluate the impact of liquid sublingual immun
Externí odkaz:
https://doaj.org/article/1cf18a041ca64146a66feda95bb63ba1
Autor:
Amandine Gouverneur, Jérôme Avouac, Clément Prati, Jean-Luc Cracowski, Thierry Schaeverbeke, Antoine Pariente, Marie-Elise Truchetet
Publikováno v:
European journal of clinical pharmacology. 78(12)
JAK-inhibitors (JAK-i) might be associated with venous (VTE) and arterial thromboembolic events (ATE). To evaluate the association between JAK-i and the risk of VTE and ATE.A self-controlled case series was performed using data from the nationwide Fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b008f8b8276eb289cd57e8e00011c2c8
https://pubmed.ncbi.nlm.nih.gov/36284012
https://pubmed.ncbi.nlm.nih.gov/36284012
Autor:
Julien Bezin, Amandine Gouverneur, Marine Pénichon, Clément Mathieu, Renaud Garrel, Dominique Hillaire-Buys, Antoine Pariente, Jean-Luc Faillie
Publikováno v:
Diabetes Care
Diabetes Care, 2022, ⟨10.2337/dc22-1148⟩
Diabetes Care, 2022, ⟨10.2337/dc22-1148⟩
International audience; OBJECTIVE: To determine whether use of glucagon-like peptide 1 (GLP-1) receptor agonists (RA) is associated with increased risk of thyroid cancer. RESEARCH DESIGN AND METHODS: A nested case-control analysis was performed with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0364723110fb8de3308b0b73b4a4cd9
https://pubmed.ncbi.nlm.nih.gov/36525594
https://pubmed.ncbi.nlm.nih.gov/36525594
Autor:
Pietro Rosellini, Samuel Amintas, Charline Caumont, Rémi Veillon, Sigolène Galland-Girodet, Alain Cuguillière, Laurent Nguyen, Charlotte Domblides, Amandine Gouverneur, Jean-Philippe Merlio, Julien Bezin, Pierre-Olivier Girodet
Publikováno v:
European journal of cancer (Oxford, England : 1990). 172
Mutations in STK11/LKB1 gene present a negative impact on tumour immune microenvironment, especially with concomitant activating KRAS mutation. These recent data may explain a decreased response to immunotherapy treatment in STK11 mutant non-small ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a926dc226500ab537f1d18639b1aac4
https://pubmed.ncbi.nlm.nih.gov/35759814
https://pubmed.ncbi.nlm.nih.gov/35759814
Autor:
Paola Sanchez-Pena, Amandine Gouverneur, G. Veyrac, Bernard Bégaud, Joe-Elie Salem, Julien Bezin
Publikováno v:
Cardiovascular Drugs and Therapy
Cardiovascular Drugs and Therapy, Springer Verlag, 2021, ⟨10.1007/s10557-021-07242-7⟩
Cardiovascular Drugs and Therapy, Springer Verlag, 2021, ⟨10.1007/s10557-021-07242-7⟩
PURPOSE: PCSK9 might affect central nervous system development, neuronal apoptosis, and differentiation. We investigate the neurocognitive adverse events associated with the use of PCSK9 inhibitors (alirocumab and evolocumab) using pharmacovigilance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::214077d6f13540132cc9cd7d2ef14192
https://hal.archives-ouvertes.fr/hal-03363610
https://hal.archives-ouvertes.fr/hal-03363610
Autor:
Xavier Berard, Pernelle Noize, Joris Guyon, Amandine Gouverneur, Sandy Maumus-Robert, Antoine Pariente, Andreas Bikfalvi
Publikováno v:
JAMA Oncol
JAMA oncology
JAMA oncology, American Medical Association, 2021, ⟨10.1001/jamaoncol.2021.0210⟩
JAMA oncology
JAMA oncology, American Medical Association, 2021, ⟨10.1001/jamaoncol.2021.0210⟩
Anticancer drugs targeting angiogenesis act either directly on vascular endothelial growth factor (VEGF) receptors (VEGF inhibitors) or VEGF-mediated intracellular processes (tyrosine kinase inhibitors) or indirectly through downstream VEGF signaling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d715e65d3d53d7d1e64e552648857c19
https://europepmc.org/articles/PMC7974832/
https://europepmc.org/articles/PMC7974832/
Autor:
Antoine Pariente, Amandine Gouverneur, Camille Morival, Amandine Ferreira, Cécile Pageot, Marie Tournier
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.14818⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.14818⟩
Background: Antipsychotics and lithium are widely used in psychiatry, particularly in schizophrenia and bipolar disorders. Recently, some cases of somnambulism or sleep-related eating disorder (SRED) have been reported in patients treated with these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4618de72a463d52939cc4f2464fcaa3a
http://hdl.handle.net/20.500.12278/27234
http://hdl.handle.net/20.500.12278/27234
Autor:
Justine Perino, Amandine Gouverneur, Marin Lahouati, F Xuereb, Noëlle Bernard, D Breilh, Fabrice Bonnet, Antoine Pariente
Publikováno v:
Thérapie
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.06.003⟩
Thérapie, EDP Sciences, 2021, ⟨10.1016/j.therap.2021.06.003⟩
Summary Purpose To date, how medication reconciliation (MR) could be prioritized in younger patients remains poorly evaluated. This study aimed at assessing whether a MR prioritization strategy based on the identification of high-risk medication at p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727c102aab23643a2402c780c5a436f9
https://pubmed.ncbi.nlm.nih.gov/34243901
https://pubmed.ncbi.nlm.nih.gov/34243901
Autor:
Mathieu Molimard, Bernard Bégaud, Emilie Casarotto, Driss Berdaï, Amandine Gouverneur, Pernelle Noize, Laurie Levy-Bachelot
Publikováno v:
Fundamentalclinical pharmacologyREFERENCES. 35(1)
Considering their novelty and cost, post-marketing evaluation is highly relevant for new anticancer drugs. Identify and characterize available and potentially useful databases for post-marketing evaluation of these specific drugs is necessary. A revi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaed23c278c162d83dcb3c0ffd328f2e
https://pubmed.ncbi.nlm.nih.gov/32740979
https://pubmed.ncbi.nlm.nih.gov/32740979